Skin And Soft Tissue Infections


  • Breakthrough Antibacterial Approach Could Resolve Serious Skin Infections
    Like a protective tent over a colony of harmful bacteria, biofilms make the treatment of skin infections especially difficult. Microorganisms protected in a biofilm pose a significant health risk due to their antibiotic resistance and recalcitrance to treatment, and ...More
    5 days ago Posted in News
  • FDA Approves Orbactiv to Treat Skin Infections
    The Food and Drug Administration has approved Orbactiv (oritavancin), a new antibacterial drug to treat adults with skin infections. Orbactiv is approved to treat patients with acute bacterial skin and skin structure infections (ABSSSI) caused by certain susceptible ...More
    4 weeks ago Posted in News
  • FDA Approves Sivextro to Treat Skin Infections
    The Food and Drug Administration (FDA) announces that it has approved Sivextro (tedizolid phosphate), a new antibacterial drug, to treat adults with skin infections. Sivextro is approved to treat patients with acute bacterial skin and skin structure infections (ABSSSI) ...More
    June 23, 2014 Posted in News
  • Increase in MRSA Prompts Updated IDSA Guidelines for Skin and Soft Tissue Infections
    The number of skin and soft tissue infections (SSTI) has skyrocketed due to the spread of methicillin resistant Staphylococcus aureus (MRSA). But many SSTIs – even those caused by the superbug MRSA – are minor and either heal on their own or are easily treated ...More
    June 19, 2014 Posted in News
  • Clinical Trial Shows Dalbavancin is as Effective as Vancomycin
    A study published in today's New England Journal of Medicine reports that the antibiotic dalbavancin is as effective as vancomycin, the current standard-of-care antibiotic used to treat serious bacterial skin and skin-structure infections. The study results establish ...More
    June 4, 2014 Posted in News
  • Investigators Report on Incidence, Cost of Hospitalizations Associated with SSTIs Caused by S. aureus
    Suaya, et al. (2014) say the emergence of community-associated methicillin-resistant Staphylococcus aureus (SA) and its role in skin and soft tissue infections (SSTIs) has accentuated the role of SA-SSTIs in hospitalizations. The researchers used the Nationwide Inpatient ...More
    June 2, 2014 Posted in News
  • FDA Approves Dalvance to Treat Skin Infections
    The Food and Drug Administration (FDA) announces it has approved Dalvance (dalbavancin), a new antibacterial drug used to treat adults with skin infections. Dalvance is intended to treat acute bacterial skin and skin structure infections (ABSSSI) caused by certain ...More
    May 29, 2014 Posted in News
  • Nasal Bacteria May Be Predictor of Skin Infections
    Bacteria found in the nose may be a key indicator for future development of skin and soft-tissue infections in remote areas of the body. Scientists have long known that a number of bacteria reside in the nose, and that those who carry the pathogen Staphylococcus aureus in ...More
    May 22, 2014 Posted in News
  • Physicians Issue New Treatment Guidelines for Skin Abscesses Caused by MRSA
    It has been more than 10 years since the clinical battle began with community-acquired methicillin-resistant Staphylococcus aureus (MRSA), and doctors are still grappling with how to diagnose, treat and prevent this virulent form of staph infection, which is immune to many ...More
    March 12, 2014 Posted in News
  • Dermatologist Provides Skin Infection Prevention Tips for Athletes
    Although many athletes understand the importance of keeping their muscles and bones healthy, it’s also important for them to take care of their skin. Sports equipment, especially protective helmets and pads, creates a warm, moist and dark environment for the germs ...More
    March 11, 2014 Posted in News
« Previous1234Next »